Ketamine Analgesic Dosing
For pure analgesia without dissociation, administer ketamine at 0.2-0.3 mg/kg IV, which provides effective pain relief while avoiding the dissociative state that occurs at higher doses.
Dose-Response Relationship
Ketamine exhibits distinct clinical effects at different dose ranges, which is critical to understand for analgesic use 1:
- Pure analgesia: 0.2-0.3 mg/kg IV
- Hallucinatory distortion: 0.6-0.7 mg/kg IV
- Dissociative threshold: 1.5-2 mg/kg IV in children; 1-1.5 mg/kg IV in adults
Unlike other sedatives, ketamine does not follow a traditional dose-response continuum—once the dissociative threshold is reached, additional doses do not deepen sedation 1.
FDA-Approved Dosing for Anesthesia
The FDA label provides these ranges, though these are for anesthetic (not purely analgesic) purposes 2:
Intravenous Route
- Initial dose range: 1-4.5 mg/kg IV
- Average anesthetic dose: 2 mg/kg IV (produces 5-10 minutes of surgical anesthesia)
- Administration: Slowly over 60 seconds to avoid respiratory depression
- Maintenance infusion: 0.1-0.5 mg/minute for general anesthesia
Intramuscular Route
- Initial dose range: 6.5-13 mg/kg IM
- Typical anesthetic dose: 9-13 mg/kg IM (produces anesthesia in 3-4 minutes, lasting 12-25 minutes)
Pediatric Analgesic Dosing
For procedural sedation in children, 1-1.5 mg/kg IV is optimal 3, 4:
- Doses of 1.5 mg/kg IV require fewer total doses and lower cumulative mg/kg compared to 1 mg/kg IV 4
- At 1-1.5 mg/kg IV, nearly 90% effectiveness was achieved 3
- Patients <2 years have higher rates of unsatisfactory analgesia (28.7%) and may require dose adjustment 3
- Procedures >20 minutes often require repeat dosing 3
Intranasal Ketamine (Pediatrics)
- Effective dose range: 3-5 mg/kg intranasal provides optimal patient comfort 5
- Bioavailability is only 50% in pediatric patients 6
- Doses between 3.6-4 mg/kg intranasal had higher failure rates (66.7%) 3
- Treatment failure rate: 7.7% overall 5
Alternative Routes
Nebulized Ketamine (Adults)
Recent evidence supports nebulized ketamine for acute pain 7:
- Effective doses: 0.7-1.5 mg/kg nebulized
- Pain reduction: 42.5% at 15 minutes, 70.4% at 120 minutes
- Higher doses (1.5 mg/kg) showed no significant advantage over lower doses (0.7 mg/kg)
- Non-inferior to IV morphine with fewer side effects
Oral Ketamine (Chronic Pain)
For chronic pain management 8:
- Recommended regimen: 0.5 mg/kg orally three times daily
- Duration: 7-90 days for chronic pain
- Bioavailability: Only 17-18% due to first-pass metabolism 6
- Mean pain reduction from 7.72/10 to 3.2/10 over 30-90 days
Critical Safety Considerations
The 100 mg/mL concentration must be diluted before IV administration 2. Dilute with equal volume of sterile water, normal saline, or D5W and use immediately.
Administration Precautions
- Administer IV doses slowly over 60 seconds—rapid administration causes respiratory depression and enhanced vasopressor response 2
- Emergency airway equipment must be immediately available 2
- Monitor vital signs and cardiac function continuously 2
- Consider antisialagogue prior to administration due to increased secretions 2
Common Pitfalls
- Arthrocentesis procedures have the highest failure rate (39.3%) with standard IV dosing 3
- Doses in the 1.6-2 mg/kg range (both initial and total) had significantly higher unsatisfactory results (11.8-17.6%) 3
- Intranasal administration has higher failure rates (36.4%) compared to IV 3
Contraindications
Ketamine is contraindicated in 2:
- Patients where blood pressure elevation would be hazardous
- Known hypersensitivity to ketamine
- Patients who have not followed NPO guidelines (relative contraindication)
Adverse Effects
Short-term: dizziness, mild dysphoria, nausea (1.5%), drowsiness (1%) 5, 9
Long-term concerns: hepatobiliary injury, cystitis with chronic use 9, 10
For pure analgesia in acute settings, start with 0.2-0.3 mg/kg IV; for procedural sedation requiring dissociation, use 1-1.5 mg/kg IV in adults or 1.5-2 mg/kg IV in children, administered slowly over 60 seconds with continuous monitoring.